Tumor volume as a predictor of survival and local control in patients with brain metastases treated with Gamma Knife surgery

Journal of Neurosurgery

Volumn 119, Issue 5, 2013, Pages 1139-1144

  Baschnagel, Andrew M ^a   Meyer, Kurt D ^a   Chen, Peter Y ^a   Krauss, Daniel J ^a   Olson, Rick E ^a   Pieper, Daniel R ^a   Maitz, Ann H ^a   Ye, Hong ^a   Grrills, Inga Siiner ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Brain metastases; Gamma Knife surgery; Oncology; Stereotactic radiosurgery; Tumor volume; Whole brain radiation therapy

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN DYSFUNCTION; BRAIN METASTASIS; BRAIN RADIATION; CANCER CONTROL; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; GAMMA KNIFE RADIOSURGERY; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; TUMOR VOLUME;

AGED; BRAIN NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOSURGERY; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84887084202     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2013.7.JNS13431     Document Type: Article

References (16)

1. Andrews DW, Scott CB, Sperduto P.W., Flanders AE, Gaspar LE, Schell MC, et al.: Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363: 1665-1672, 2004 (Pubitemid 38670323)
2. Aoyama H, Shirato H, Tago M., Nakagawa K, Toyoda T, Hatano K., et al.: Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295: 2483-2491, 2006 (Pubitemid 43854963)
3. Baschnagel A, Wolters PL, Camphausen K: Neuropsychological testing and biomarkers in the management of brain metastases. Radiat Oncol 3: 26, 2008
4. Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD: Stereotactic radiosurgery for four or more intracranial metastases. Int J Radiat Oncol Biol Phys 64: 898-903, 2006 (Pubitemid 43183591)
5. Chang EL, Wefel JS, Hess K.R., Allen PK, Lang FF, Kornguth DG, et al.: Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10: 1037-1044, 2009
6. Gaspar L, Scott C, Rotman M., Asbell S, Phillips T, Wasserman T., et al.: Recursive partitioning analysis (RPA) of prog nostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37: 745-751, 1997 (Pubitemid 27181303)
7. Grandhi R, Kondziolka D, Panczykowski D., Monaco EA III, Kano H, Niranjan A, et al.: Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases. Clinical article. J Neurosurg 117: 237-245, 2012
8. Hunter GK, Suh JH, Reuther A.M., Vogelbaum MA, Barnett GH, Angelov L, et al.: Treatment of five or more brain metastases with stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 83: 1394-1398, 2012
9. Kocher M, Soffietti R, Abacioglu U., Villà S, Fauchon F, Baumert BG, et al.: Adjuvant whole-brain radiotherapy versus ob ser vation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 29: 134-141, 2011
10. Kondziolka D, Kano H, Harrison GL, Yang HC, Liew DN, Niranjan A, et al.: Stereotactic radiosurgery as primary and salvage treatment for brain metastases from breast cancer. Clinical article. J Neurosurg 114: 792-800, 2011
11. Likhacheva A, Pinnix CC, Parikh N.R., Allen PK, McAleer MF, Chiu MS, et al.: Predictors of survival in contemporary practice after initial radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 85: 656-661, 2012
12. Meyers CA, Smith JA, Bezjak A, Mehta M.P., Liebmann J., Illidge T, et al.: Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 22: 157-165, 2004 (Pubitemid 41095128)
13. Serizawa T, Hirai T, Nagano O., Higuchi Y, Matsuda S, Ono J., et al.: Gamma knife surgery for 1-10 brain metastases without prophylactic whole-brain radiation therapy: analysis of cases meeting the Japanese prospective multi-institute study (JLGK0901) inclusion criteria. J Neurooncol 98: 163-167, 2010
14. Shaw E, Scott C, Souhami L., Dinapoli R, Kline R, Loeffler J., et al.: Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05 Int J Radiat Oncol Biol Phys 47: 291-298, 2000 (Pubitemid 30236367)
15. Sperduto PW, Kased N, Roberge D., Xu Z, Shanley R, Luo X., et al.: Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 30: 419-425, 2012
16. Suh JH: Stereotactic radiosurgery for the management of brain metastases. N Engl J Med 362: 1119-1127, 2010